Please login to the form below

Infographic: HCV - The Roadblocks to Effective Treatment

Referencing data from our Living with HCV survey undertaken with patients in the US and China, this infographic explores the roadblocks encountered on the path to effective and compliant treatment.

Hepatitis C is a chronic infection of the liver caused by the caontagious hepatitis C virus (HCV). blood-borne, the virus attacks cells in the liver where is multiplies causing inflammation, cirrhosis and ultimately liver failure. According to the World Health Organisation, around 150 million people worldwide are chronically infected with HCV, and more than 350,00 people die as a result of a HCV related liver disease. Following initial infection, approximately 80% of people do not exhibit any symptoms and lead normal lives for many years.

This infographic explores the various roadblocks patients encounter on the path to effective and compliant treatment from diagnosis, to treatment and pill burden and side effects.

Download the infographic at

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges. 

19th May 2015


Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Chester House
Fulham Green
81-83 Fulham High Street
United Kingdom

Latest content on this profile

Medical Technology specialist joins Research Partnership
Research Partnership
Live webinar
The power of a good story: Turn your insights into effective storytelling with data visualisation
Research Partnership
How will COVID-19 affect uptake of vaccinations against other diseases?
Research Partnership
Living With Chronic Illness (Series one)
Research Partnership
Live webinar
China: How pharma can maximize success in this rapidly changing emerging market
Research Partnership
Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma
Research Partnership